tiprankstipranks
Trending News
More News >
Eurofins-Cerep SA (DE:ZEP2)
MUNICH:ZEP2
Advertisement

Eurofins-Cerep SA (ZEP2) Price & Analysis

Compare
0 Followers

ZEP2 Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

ZEP2 FAQ

What was Eurofins-Cerep SA’s price range in the past 12 months?
Currently, no data Available
What is Eurofins-Cerep SA’s market cap?
Currently, no data Available
When is Eurofins-Cerep SA’s upcoming earnings report date?
Eurofins-Cerep SA’s upcoming earnings report date is Apr 09, 2026 which is in 193 days.
    How were Eurofins-Cerep SA’s earnings last quarter?
    Eurofins-Cerep SA released its earnings results on Sep 18, 2025. The company reported €360.825 earnings per share for the quarter, beating the consensus estimate of N/A by €360.825.
      Is Eurofins-Cerep SA overvalued?
      According to Wall Street analysts Eurofins-Cerep SA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Eurofins-Cerep SA pay dividends?
        Eurofins-Cerep SA does not currently pay dividends.
        What is Eurofins-Cerep SA’s EPS estimate?
        Eurofins-Cerep SA’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Eurofins-Cerep SA have?
        Currently, no data Available
        What happened to Eurofins-Cerep SA’s price movement after its last earnings report?
        Eurofins-Cerep SA reported an EPS of €360.825 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
          Which hedge fund is a major shareholder of Eurofins-Cerep SA?
          Currently, no hedge funds are holding shares in DE:ZEP2

          Company Description

          Eurofins-Cerep SA

          Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.

          Eurofins-Cerep SA (ZEP2) Earnings & Revenues

          Similar Stocks
          Company
          Price & Change
          Follow
          Innate Pharma SA
          Eurofins Scientific
          OSE Immunotherapeutics SA
          Lumibird SA
          Sensorion SAS
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis